Skip to content
Use caution Drug recall · FDA · Published April 28, 2015

Fresenius Kabi Recalls KABIVEN Due to Labeling Error

Fresenius Kabi recalls KABIVEN injectable emulsion bags due to a labeling error where amino acid strength is incorrectly declared. Check lot numbers and expiry dates.

🇺🇸 FDA recall #D-1114-2015DrugFresenius Kabi ›
Take action

Contact the company

Recalling firmFresenius Kabi USA, LLC3 Corporate Dr · Lake Zurich, IL 60047-8930
✎ GovInfoNow plain-language explainer

Fresenius Kabi USA, LLC is recalling specific lots of KABIVEN, an injectable emulsion containing lipids, amino acids, electrolytes, and dextrose. The recall is necessary because the product's labeling incorrectly states the amino acid strength as 3.1% when it actually contains 3.3%. This discrepancy affects the accuracy of the nutritional information provided on the package. Read more at govinfonow.com/recall/44723-fresenius-kabi-usa-llc-recalls-kabiven-3-9-lipid-injectable.

Source Summary by GovInfoNow · govinfonow.com/recall/44723-fresenius-kabi-usa-llc-recalls-kabiven-3-9-lipid-injectable · Updated October 12, 2026 · FDA enforcement record: FDA #D-1114-2015

Cite this page

“Fresenius Kabi Recalls KABIVEN Due to Labeling Error.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/44723-fresenius-kabi-usa-llc-recalls-kabiven-3-9-lipid-injectable. Based on FDA recall #D-1114-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1114-2015%22&limit=1).

The FDA announced on April 28, 2015, that Fresenius Kabi USA, LLC voluntarily recalled KABIVEN Injectable Emulsion due to a labeling error where the product contained 3.3% amino acids instead of the declared 3.1%. The recall affects 5,488 bags distributed nationwide.

How to tell if you have it

  • Brand: Fresenius Kabi
  • Product: KABIVEN [(3.9%) Lipid Injectable Emulsion with (3.1%) Amino Acids and Electrolytes and (9.8%) Dextrose; Sulfite-free]
  • NDC 63323-712-15, Lot # 10HH8781, Expiry: 07-2016
  • NDC 63323-712-20, Lot # 10HH8739, Expiry: 07-2016

The hazard

The product was labeled with 3.1% amino acids but actually contained 3.3% amino acids. The FDA classified this labeling error as a Class II recall.

Context

GovInfoNow's records show Fresenius Kabi USA, LLC has 65 other recalls on record since September 27, 2012. Other recent recalls of similar products include Fresenius Kabi Tyenne Injection Recall (August 10, 2026), Fresen Morphine Syringes May Have Wrong Labeling (August 4, 2026), and Fresenius Kabi Lidocaine HCl Injection Recall (July 16, 2026). Other recent recalls of similar products include Slate Run Recalls Eptifibatide Injection Due to Labeling Error (February 12, 2026), ICU Medical Recalls Potassium Chloride Injection Due to Label Error (October 29, 2025), and Otsuka ICU Medical Potassium Chloride Inj. 20mEq Label Error Recall (October 29, 2025).

How to tell if you have this one

Look for KABIVEN [(3.9%) Lipid Injectable Emulsion with (3.1%) Amino Acids and Electrolytes and (9.8%) Dextrose; Sulfite-free] in 1,540 mL or 2,053 mL bags. Check for NDC numbers 63323-712-15 or 63323-712-20. Affected lots are 10HH8781 and 10HH8739, both with an expiry date of 07-2016.

  • Brand
    Fresenius Kabi
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Lot Numbers

    Verify if your inventory includes lots 10HH8781 or 10HH8739 with an expiry date of 07-2016.

  2. Contact Manufacturer

    Reach out to Fresenius Kabi USA, LLC for further instructions on how to handle the recalled product.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “US; Nationwide, including Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 13 months after the firm started it.

1. Firm started the recall: Apr 28, 201512. FDA classified it Class II: Jun 3, 201523. Published in FDA’s Enforcement Report: Jun 10, 201534. FDA terminated the recall: May 19, 2016420152016
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Fresenius Kabi recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1114-2015 (April 28, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1114-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA